Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.86 +0.04 (+2.20%)
At close: Nov 10, 2026 · 4:00 PM EST

Lexicon Pharmaceuticals (LXRX) Finished Goods (2023)

Updated

Lexicon Pharmaceuticals' Finished Goods was $172,000 in Q2 2023.

Analysis

Lexicon Pharmaceuticals (LXRX) Finished Goods (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Lexicon Pharmaceuticals 860.99 Mn 220.29 Mn 11.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 172,000.00
API Access

Lexicon Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=LXRX&period=max&api_key=YOUR_API_KEY